Essayer OR - Gratuit
InvAscent aims to sell stake in Aizant Drug
Mint Mumbai
|January 03, 2024
The stake-sale deal is expected to value the drug firm at 350-4.00 million
Healthcare-focused private equity firm InvAscent is looking to sell its stake in Aizant Drug Research Solutions Pvt. Ltd in a deal expected to value the drug development company at $350-400 million.
So far, InvAscent has poured $18 million into the Hyderabad-based company. It now aims to sell a controlling stake in Aizant, with the promoters retaining their share, three people with knowledge of the development said.
"Private equity funds have been reached out to for a controlling stake sale," one of them said.
Global investment bank Rothschild has been appointed to look for buyers, another person said. "The (information memorandum) was sent out last month," this person said.
Cette histoire est tirée de l'édition January 03, 2024 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
TCS, Wipro US patent suits worsen IT's woes
Two of the country’s largest information technology (IT) services companies—Tata Consultancy Services Ltd and Wipro Ltd—faced fresh patent violations in the last 45 days, signalling challenges to their expansion of service offerings.
2 mins
November 25, 2025
Mint Mumbai
AI bond flood adds to market pressure
Wall Street is straining to absorb a flood of new bonds from tech companies funding their artificial intelligence investments, adding to the recent pressure in markets.
4 mins
November 25, 2025
Mint Mumbai
Auto parts firms spot hybrid gold
Auto component makers are licking their lips at the ascent of hybrids, spying a new growth engine at a time when electric vehicle (EV) sales have not measured up.
2 mins
November 25, 2025
Mint Mumbai
Diwali is past, but shopping season is roaring ahead
India's consumption engine appears to be humming well past the Diwali rush, with digital payments showing none of the usual post-festival fatigue.
3 mins
November 25, 2025
Mint Mumbai
HOW TO SPOT A WINNING STARTUP IPO
As a flood of new listings burns small investors, we investigate the overlooked metrics
9 mins
November 25, 2025
Mint Mumbai
WHY INDIA HAS FAILED TO CURB AIR POLLUTION
Despite massive funding, India has failed to make meaningful progress in combating air pollution. Beijing's dramatic turnaround over the past decade offers crucial lessons.
4 mins
November 25, 2025
Mint Mumbai
Micro biz has a harder time securing loan to start up
Bank lending to first-time micro-entrepreneurs has plummeted, signalling tighter credit conditions for small businesses already struggling with cash flow pressures and trade turmoil. In the first six months of the fiscal year, a key central scheme to support such lending managed to sanction just about 12% of what was sanctioned in the entire previous fiscal year, official data showed.
2 mins
November 25, 2025
Mint Mumbai
Inverted duty fix is next on GST agenda
GST Council to expand work on fixing anomaly at next meet
2 mins
November 25, 2025
Mint Mumbai
Why was a fresh approach to QCOs needed?
The government is now withdrawing the quality control orders (QCOs) issued earlier across sectors. Mint examines the original intent, the reasons for the policy reversal, and the expected national benefits from this move.
2 mins
November 25, 2025
Mint Mumbai
Climate: Hope lives
Climate change could be described as a \"tragedy of the commons.\" That is, one where a shared resource, such as the planet's atmosphere, gets degraded because everyone has an incentive to put immediate self-interest above what's good for all.
1 min
November 25, 2025
Translate
Change font size

